Serum Apelin Level in Type 2 Diabetic Mellitus Patients and Its Association With Metabolic Syndrome Components

Hayder Abdulameer Hammood Saadi, Mahdieh Safarzad, Nahid Poursharifi, Mahin Tatari, Abdoljalal Marjani

Abstract


Background: Metabolic syndrome (MetS) is a multiple risk factor for metabolic diseases. Apelin plays a crucial role in controlling insulin sensitivity and secretion in animals. The study aimed to clarify the difference in serum apelin between Iranain subjects with MetS and type 2 diabetes mellitus (T2DM), and subjects without MetS and its association with MetS components.

Methods: The study was conducted on 196 individuals, including 98 Iranian subjects with MetS and T2DM, and 98 age- and sex-matched individuals without MetS. MetS was defined using Adult Treatment Panel III (ATP-III) guidelines.

Results: Serum apelin level was significantly lower in subjects with MetS than those without MetS. There was a negative correlation between apelin and fasting blood glucose (FBG) in subjects with MetS and in both sexes (P < 0.05).

Conclusions: The apelin level in Iranian T2DM subjects with MetS is related to FBG. Apelin is thought to affect glucose metabolism and insulin resistance. Apelin may be an essential indicator in Iranian T2DM people and may play an important role in preventing diabetes complications in T2DM patients.




J Endocrinol Metab. 2023;13(2):81-87
doi: https://doi.org/10.14740/jem876

Keywords


Apelin; Metabolic syndrome components; Type 2 diabetic patients

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

  

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

  

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

  

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

  

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

  
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.